Login to Your Account



$320M Milestones Per Product

NeuroSearch in Blockbuster Ion Channel Deal with Lilly

By Cormac Sheridan


Wednesday, February 18, 2009
NeuroSearch A/S shrugged off disappointment in the clinic last week - namely, the failure of ABT-894 in a Phase II trial in diabetic neuropathic pain - with a three-year central nervous system drug discovery alliance with Eli Lilly and Co. that has the potential to grow to blockbuster proportions.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription